Utrogestan / Utrogestan 200Mg 100mg / 200mg Capsule. Oral
PDF Leaflet Revision Date: 13 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Progesterone deficiency disorders and luteal phase support.
Dosage (summary)
200-300 mg/day orally; 100-600 mg/day vaginally depending on indication.
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use restricted to first trimester via vaginal route; not recommended during breastfeeding.
Key Drug Interactions
- Enzyme inducers (e.g., carbamazepine)
- Enzyme inhibitors (e.g., ketoconazole)
- Ciclosporin
Contraindications
- Known sensitivity to progesterone
- Severe liver disease
- Undiagnosed vaginal bleeding
- Breastfeeding
Common side effects
- Dizziness
- Drowsiness
- Abdominal cramping
- Amenorrhoea
Counselling Points
- Take after eating
- May cause drowsiness
- Report any unusual bleeding
Serious warnings
- Discontinue if liver function tests abnormal
- Risk of thromboembolism
- Not contraceptive
Important Disclaimer
The Utrogestan / Utrogestan 200Mg 100mg / 200mg Capsule. Oral professional information leaflet below is the property of Medi Challenge and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
